{"filing":{"accession_number":"0001193125-26-263844","cik":"0001478320","ticker":"ADPT","company_name":"Adaptive Biotechnologies Corp","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"adpt-20260605.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1478320/000119312526263844/adpt-20260605.htm"},"events":[{"id":5928,"run_id":5201,"accession_number":"0001193125-26-263844","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from Adaptive Biotechnologies' June 5, 2026 annual meeting, covering three proposals: election of two Class I directors (Hershberg and Owen), advisory vote on 2025 named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed voting tallies and percentages match the shareholder_vote_results taxonomy precisely, and the results are material to investors assessing board composition and governance.","company_name":"Adaptive Biotechnologies Corp","ticker":"ADPT","filing_date":"2026-06-09","form":"8-K","submitted_at":null,"items":[{"id":5564,"accession_number":"0001193125-26-263844","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Adaptive Biotechnologies' June 5, 2026 annual meeting, covering three proposals: election of two Class I directors (Hershberg and Owen), advisory vote on 2025 named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed voting tallies and percentages match the shareholder_vote_results taxonomy precisely, and the results are material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:32:23.217163+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5564,"accession_number":"0001193125-26-263844","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Adaptive Biotechnologies' June 5, 2026 annual meeting, covering three proposals: election of two Class I directors (Hershberg and Owen), advisory vote on 2025 named executive officer compensation, and ratification of Ernst \u0026 Young LLP as independent auditor. The detailed voting tallies and percentages match the shareholder_vote_results taxonomy precisely, and the results are material to investors assessing board composition and governance.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:32:23.217163+00:00","company_name":"Adaptive Biotechnologies Corp","ticker":"ADPT","filing_date":"2026-06-09"}]}